Brief: Catabasis Pharmaceuticals Reports Q3 2020 Results

Astria Therapeutics

12/11/2020 21:44

Nov 12 (Reuters) - Catabasis Pharmaceuticals Inc  CATB.O :
    * CATABASIS PHARMACEUTICALS REPORTS THIRD QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.56
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.51 -- REFINITIV IBES
DATA
    * CASH AND CASH EQUIVALENTS TOTALED $52.9 MILLION AS OF
SEPTEMBER
30, 2020
    * EXPECTS THAT IT HAS SUFFICIENT CASH TO FUND OPERATIONS FOR
AT
LEAST NEXT 12 MONTHS

Source text for Eikon:  ID:nBwb56bdja 
Further company coverage:  CATB.O 

 ((Reuters.Briefs@thomsonreuters.com;))